Stocks in News: Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) made a new 52-week high of $16.38 today on traded volume of 1.02 million shares. The development-stage pharmaceutical company recently announced positive results from a clinical trial of its oral insulin capsule in type 1 diabetes patients. ORMP shares are trading in the range of $11.38 to $16.38 in the current trading session. The company has […]